Latest stories on KTTA
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial | KTTA Stock News
StockTitan58 · neutralproduct/pr
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference | KTTA Stock News
StockTitan67 · bullishproduct/pr